Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography

Edwin Nkansah1, Rahi Shah, Gavin W Collie

  • 1Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, London, United Kingdom.

FEBS Letters
|February 26, 2013
PubMed

Insights

Unphosphorylated STAT3 (Signal Transducer and Activator of Transcription 3) can bind DNA directly, challenging previous assumptions. This finding impacts our understanding of STAT3

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Protein-DNA Interactions

Background:

  • Signal Transducer and Activator of Transcription 3 (STAT3) is frequently over-expressed in various cancers.
  • Previously, STAT3 phosphorylation was considered essential for its direct DNA binding activity.

Purpose of the Study:

  • To investigate the DNA binding capabilities of unphosphorylated STAT3 (uSTAT3).
  • To elucidate the mechanism of STAT3 core binding to its high-affinity target DNA sequence (M67 DNA).

Main Methods:

  • Protein electrophoretic mobility shift assay (PEMSA) was used to assess STAT3-DNA binding.
  • X-ray crystallography was employed to determine the structural basis of STAT3-DNA interaction.
  • Competition assays with phosphotyrosyl peptides were performed to evaluate the role of phosphorylation.

Main Results:

  • Purified unphosphorylated STAT3 core demonstrated complete binding to M67 DNA.
  • Binding of uSTAT3 to M67 DNA was inhibited by increasing concentrations of a phosphotyrosyl peptide.
  • X-ray crystallography revealed a binding mode for uSTAT3 similar to phosphorylated STAT3.

Conclusions:

  • Direct DNA binding of STAT3 is not strictly dependent on its phosphorylation.
  • Unphosphorylated STAT3 can bind to its high-affinity DNA target, suggesting alternative regulatory mechanisms.
  • These findings offer new insights into STAT3 function in cancer and potential therapeutic strategies.